Skip to main content

Joe Jeffery on the "Safer Use Model" for PEDs & Performance Enhancement

Renaissance PeriodizationJune 15, 20251h 44min86,832 views
33 connections·40 entities in this video→

Understanding the "Safer Use Model" (Harm Reduction)

  • πŸ’‘ Joe Jeffery clarifies that there is no truly safe way to use Performance Enhancing Drugs (PEDs) for bodybuilding outcomes, preferring the term "harm reduction".
  • 🎯 The goal is to achieve desired physique results while reducing risks and negative health costs compared to less structured approaches.
  • πŸ”‘ This model focuses on restructuring stack design to be more favorable for health outcomes, rather than solely reducing total drug exposure.

Optimizing Steroid Stacks

  • πŸ”¬ A balanced approach involves managing the androgen to estrogen ratio, not just total estrogen levels.
  • πŸ§ͺ For a massing phase, a foundational stack includes testosterone for its crucial role in health and physique, supplemented by a DHT derivative (like Masteron or Primobolan) to manage the androgen-estrogen balance.
  • ⚠️ Signs of high estrogen, such as gynecomastia or fluid retention, indicate a need to adjust the stack, potentially by increasing the DHT derivative component.
  • πŸ“Š DHT derivatives are favored due to their extensive human clinical data and approved use, unlike many research chemicals.

Growth Hormone and Insulin in Cycles

  • πŸš€ Growth hormone is presented as a facilitator for anabolism, synergizing with testosterone to enhance IGF-1 production in muscle cells.
  • πŸ“ˆ While GH alone doesn't build muscle, it aids in nutrient partitioning and anti-lipogenesis, making fat gain more difficult during a massing phase.
  • πŸ’§ Insulin, particularly basal insulins, can assist with nutrient partitioning and intramuscular volume, but its use requires careful monitoring due to potential impacts on insulin sensitivity.
  • ⚠️ The use of insulin is cautioned against during fat loss phases due to its potential to attenuate the lipolytic effects of other compounds.

Peptides and Future of Performance Enhancement

  • ✨ GLP-1 agonists (like Semaglutide and Retatrutide) are highlighted for their significant impact on appetite regulation and potential psychological benefits by reducing "food noise."
  • πŸ’ͺ Future advancements like myostatin inhibitors combined with other pathways show promise for non-androgenic muscle accretion, potentially revolutionizing physique enhancement within years.
  • 🚫 Currently, SARMs are not considered as promising as initially touted due to off-target side effects at effective doses, with steroidal SARMs like Primobolan and Masteron being the closest available options.

Ancillary Drugs and Health Support

  • πŸ›‘οΈ Metformin is recommended for its antioxidant and anti-inflammatory properties, helping to mitigate oxidative stress from PED use.
  • ❀️ Telmisartan is advised for managing blood pressure and mitigating the negative cardiac outcomes associated with androgen use by blocking angiotensin II.
  • πŸ’Š Vitamins and minerals are crucial, with an emphasis on obtaining them through a nutrient-dense diet of fruits and vegetables, supplemented by targeted antioxidants like taurine and glutathione.

Managing Stress and Nervous System Health

  • 🧠 Nervous system regulation is critical for long-term health and performance, with excessive sympathetic drive from training, dieting, and stimulant use being detrimental.
  • 🧘 Practices like self-regulated breathing and meditation are encouraged to increase parasympathetic tone, aiding recovery, sleep, and overall well-being.
  • πŸ“‰ GLP-1 agonists can indirectly support nervous system health by reducing sympathetic drive associated with hunger and stress.

TRT Dad Protocol and Blood Work

  • πŸ‘¨β€βš•οΈ A "TRT dad" protocol might involve 200-300mg of testosterone weekly, with potential additions like growth hormone, metformin, and telmisartan for sustained health and physique benefits.
  • 🩺 Regular blood work (every 3-6 months for competitors, annually for TRT users) is essential, including markers like Cystatin C, HbA1c, and lipid panels, alongside echocardiograms every 6-12 months to monitor cardiac health.
  • πŸ“Š Detailed logs of PED use and regular cardiac monitoring help in making informed decisions to prevent long-term health issues.
Knowledge graph40 entities Β· 33 connections

How they connect

An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.

Hover Β· drag to explore
40 entities
Chapters17 moments

Key Moments

Transcript387 segments

Full Transcript

Topics18 themes

What’s Discussed

Performance Enhancing Drugs (PEDs)Harm ReductionSteroid StackingTestosteroneDHT DerivativesEstrogen ManagementGrowth HormoneInsulinPeptidesGLP-1 AgonistsSARMsMetforminTelmisartanAntioxidantsNervous System RegulationTRT (Testosterone Replacement Therapy)Blood WorkEchocardiogram
Smart Objects40 Β· 33 links
PeopleΒ· 4
ConceptsΒ· 22
ProductsΒ· 11
CompaniesΒ· 2
LocationΒ· 1